Inventor · disambiguated record
Guosheng Wu
Also filed as: WU GUOSHENG
19 granted patents·18 pending applications·27 citations·filing 2010–2023
90Inventor score
Files withGENENTECH INC23VITAE PHARMACEUTICALS INC3QILU PHARMACEUTICAL CO LTD2XRAD THERAPEUTICS INC2CACATIAN SALVACION1
Top patents by PatentIndex Score
37 records- 0188US9605005B2Alkynyl alcohols and methods of useGENENTECH INC·Filed 2016·Granted Mar 28, 2017·5 cites·4 claims
- 0285US8633212B2Inhibitors of beta-secretaseCACATIAN SALVACION·Filed 2010·Granted Jan 21, 2014·10 cites·22 claims
- 0380US10800780B2TDO2 InhibitorsGENENTECH INC·Filed 2016·Granted Oct 13, 2020·4 cites·17 claims
- 0476US11603373B2TDO2 and IDO1 inhibitorsGENENTECH INC·Filed 2018·Granted Mar 14, 2023·2 cites·17 claims
- 0575US12187742B2Dual ATM and DNA-PK inhibitors for use in anti-tumor therapyXRAD THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·1 cites·25 claims
- 0672US11236046B2Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulatorsGENENTECH INC·Filed 2019·Granted Feb 1, 2022·0 cites·1 claims
- 0771US9045500B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jun 2, 2015·1 cites·10 claims
- 0870US10336717B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2015·Granted Jul 2, 2019·1 cites·9 claims
- 0970US10065970B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Sep 4, 2018·1 cites·18 claims
- 1070US9212153B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2013·Granted Dec 15, 2015·1 cites·23 claims
- 1167US8889703B2Inhibitors of beta-secretaseDILLARD LAWRENCE W·Filed 2011·Granted Nov 18, 2014·1 cites·12 claims
- 1261US2024092779A1Usp1 inhibitors and uses thereofZENTAUR THERAPEUTICS USA INC·Filed 2023·Application pending·0 cites
- 1359US2018282272A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1458US2016096850A9Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 1558US2015057260A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 1657US2022249487A1Quinazolinyl compounds and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 1757US2018118680A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2017·Application pending·0 cites
- 1856US10647731B2Thiazolopyrimidinones and methods of use thereofGENENTECH INC·Filed 2018·Granted May 12, 2020·0 cites·70 claims
- 1955US12358951B2Cyclic peptide antibioticsGENENTECH INC·Filed 2021·Granted Jul 15, 2025·0 cites·22 claims
- 2055US12344603B2Pyrido-pyrimidinone and pteridinone compounds and methods of useGENENTECH INC·Filed 2021·Granted Jul 1, 2025·0 cites·26 claims
- 2153US2022204498A1Pyrido-pyrimidinyl compounds and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 2253US2024383915A1Oxazepine compounds and uses thereof in the treatment of cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 2353US2016221945A1Substituted heterocyclic sulfonamide compounds useful as trpa1 modulatorsGENENTECH INC·Filed 2016·Application pending·0 cites
- 2452US2017210724A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 2552US2017145034A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 2652US2024317686A1RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOFSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 2750US10435414B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2018·Granted Oct 8, 2019·0 cites·23 claims
- 2849US2023219986A1Novel aminopyrimidine egfr inhibitorQILU PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2949US2016185797A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2016·Application pending·0 cites
- 3049US2024034743A9Tricyclic compounds as egfr inhibitorsQILU PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3149US2022142995A1Dual atm and dna-pk inhibitors for use in anti-tumor therapyXRAD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3248US2025275965A1Compounds as casein kinase inhibitorsGRITSCIENCE BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3347US11279735B2Cyclic peptide antibioticsGENENTECH INC·Filed 2020·Granted Mar 22, 2022·0 cites·28 claims
- 3444US9988400B2Thiazolopyrimidinones and methods of use thereofGENENTECH INC·Filed 2016·Granted Jun 5, 2018·0 cites·70 claims
- 3543US10280165B2Pyridopyrimidinones and methods of use thereofGENENTECH INC·Filed 2017·Granted May 7, 2019·0 cites·28 claims
- 3642US11911353B2Fatty acid synthase inhibitor and application thereofUNIV JIANGNAN·Filed 2020·Granted Feb 27, 2024·0 cites·13 claims
- 3733US2022041616A1Spiro compound and medical uses thereofTHE NAT INSTITUTES OF PHARMACEUTICAL R&D CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guosheng Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →